| Heading: |
Respiratory System: Diseases |
| Question ID: |
1745339 |
| UIN: |
HL3003 |
| House: |
Lords |
| Date tabled: |
2024-11-27 |
| Asking Member ID: |
4130 |
| Asking Member display name: |
Baroness Ritchie of Downpatrick
|
| Asking Member handle: |
MRitchieSD
|
| Asking Member Twitter reference: |
@MRitchieSD
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what assessment they have made of the role of financial incentives in improving access to respiratory care and treatment. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-04 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
There is a wide range of work taking place across NHS England to support the implementation of the recommendations of National Institute for Health and Care Excellence. In relation to access to diagnosis, NHS England has published commissioning standards,... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |